Tag Archives: atherosclerosis
September 2008 Br J Cardiol 2008;15:237-39
CVD risk and beyond at H·E·A·R·T UK conference 2008
BJC editorial team
Risk calculation Dr Peter Brindle, the Research and Development Director and GP at the Bristol Primary Care Trust, lit the spark by taking the first lecture spot. With the title Advances and Controversies in CVD Risk Estimation he was stepping into the lions’ den. Earlier in the year H·E·A·R·T UK welcomed the continued use of well-established and validated risk calculation tools within the National Institute of Health and Clinical Excellence (NICE) lipid modification guideline and had endorsed the guideline group’s decision not to recommend more novel experimental approaches. So the delegates were keen to hear Dr Brindle announce the
September 2008 Br J Cardiol 2008;15:261-5
Renal and cardiac arterial disease: parallels and pitfalls
Timothy Bonnici, David Goldsmith
Introduction Renal artery stenosis (RAS), traditionally the preserve of the nephrologist, is a condition of increasing interest to the cardiologist. Ninety per cent of RAS is caused by atherosclerosis and the risk factors for renal atherosclerosis and coronary atherosclerosis are the same. Furthermore, the presence of RAS alters the prognosis of co-existent cardiac disease, most notably cardiac failure and ischaemic heart disease, both directly1–3 and via its sequelae of renal failure and hypertension. Finally, the treatments for the disease, both medical and interventional, are familiar to the cardiologist, who can employ much of the knowl
May 2008 Br J Cardiol 2008;15:123–30
News from the 57th annual scientific session of the American College of Cardiology
Terry McCormack
ENHANCE controversy dominates meeting The controversial ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolaemia Enhances Atherosclerosis Regression) trial of ezetimibe dominated the ACC meeting, with a special session held to discuss the results, which were simultaneously published in the New England Journal of Medicine. The 720-patient trial showed no benefit of ezetimibe when added to simvastatin 80 mg in slowing the progression of atherosclerosis in the carotid artery (as measured by intima media thickness (IMT) in patients with familial hypercholesterolemia (FH), despite the fact that there were significantly greater reductions in lo
November 2006 Br J Cardiol 2006;13:386-90
News from the Scientific Sessions 2006 of the American Heart Association
BJCardio editorial team
No content available
May 2006 Br J Cardiol 2006;13:174-6
The American Society of Hypertension 21st Annual Scientific Meeting
Martin Godfrey
No content available
March 2006 Br J Cardiol 2006;13:131-6
The failure of LDL cholesterol reduction and the importance of reverse cholesterol transport. The role of nicotinic acid
H Robert Superko
No content available
July 2003 Br J Cardiol 2003;10:273-80
EBCT coronary calcium imaging for the early detection of coronary artery disease in asymptomatic individuals
D Vijay Anand, Avijit Lahiri, David Lipkin
No content available
July 2002 Br J Cardiol 2002;9:394-400
Atherosclerosis imaging and coronary calcification
Matthew J Budoff
No content available
July 2002 Br J Cardiol 2002;9:373-6
Atherosclerosis imaging and coronary calcification: the UK perspective
Gareth J Morgan-Hughes, Carl A Roobottom, Andrew J Marshall
No content available
For healthcare professionals only
